News

This MS awareness month, Dr. Carolina Garcia, a neurologist at Saint Luke's Comprehensive Multiple Sclerosis Center, discusses diagnosing and treating this inflammatory and presumed autoimmune condition.

A local man with heart failure who was told numerous times he only had months to live gets a second chance at life after treatment at Saint Luke's.

Growing research shows why popular GLP-1 weight loss medications might be beneficial for people with multiple sclerosis, but the jury’s still out.

Dr. Adnan Chhatriwalla, interventional cardiologist at Saint Luke’s Mid America Heart Institute, talks about symptoms of heart valve disease, treatment, and keys to long-term heart health.

Empower yourself by learning all you can about therapies for multiple sclerosis.

One patient's experience more than a decade ago was a pivotal moment for both Saint Luke’s Mid America Heart Institute and Saint Luke's Hospital Maternal-Fetal Medicine Program.

Jennifer Sonsiadek, Nurse Manager of Saint Luke’s Clinical Forensic Program, talks to KCTV about how Saint Luke’s has been leading the way and innovating clinical forensic care provided in Kansas City and the nation for 50 years.

The care a person receives immediately following abuse or assault has a significant effect on their physical, emotional, and psychological well-being.

FOX4 talked to Dr. Karin Olds about Guillain-Barre Syndrome and recovery.

A recent study out of Harvard School of Public Health found a strong relationship between those who had mononucleosis, or the “kissing disease,” and multiple sclerosis later in life.